Stephen Smolinski

Stephen Smolinski

Plus aucun poste en cours
61 ans
Health Technology
Consumer Services

Profil

Stephen Smolinski worked at Savient Pharmaceuticals, Inc. from 2011 to 2013 as Vice President-Marketing from 2012 to 2013.
From 2015 to 2017, worked at Genzyme Therapeutics Ltd. as VP & Head-North American Rheumatology Business.
From 2017 to 2020, worked at Selecta Biosciences, Inc. as Chief Commercial Officer.
Also worked at Swedish Orphan Biovitrum AB as Global Head-Immunology Therapeutic Area, at Avalo Therapeutics, Inc. as Chief Commercial Officer, and at Precigen, Inc. as Senior VP & Head-Business Development.
Education includes undergraduate studies at Oregon State University.

Anciens postes connus de Stephen Smolinski

SociétésPosteFin
CARTESIAN THERAPEUTICS, INC. Corporate Officer/Principal 18/08/2020
Corporate Officer/Principal 01/01/2017
SAVIENT PHARMACEUTICALS INC Sales & Marketing 01/06/2013
PRECIGEN, INC. Corporate Officer/Principal -
SWEDISH ORPHAN BIOVITRUM AB Corporate Officer/Principal -
Voir l'expérience en détail de Stephen Smolinski

Formation de Stephen Smolinski

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Relations

26

Relations au 1er degré

7

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Sociétés liées

Entreprise privées7

Health Technology

Health Technology

Health Technology

Consumer Services

Health Technology

Health Technology

Health Technology

  1. Bourse
  2. Insiders
  3. Stephen Smolinski
- 40% : Les Meilleurs Outils Réservés aux Abonnés pour Identifier les Meilleurs Investissements de Demain !
j
:
:
PROFITEZ-EN MAINTENANT